FDA Focus: What Loeb & Loeb's Practice Chair Is Watching
Scott Liebman, head of the U.S. Food and Drug Administration practice at Loeb & Loeb LLP, tells Law360 that he's watching drugmakers loosen up on social media, tracking a high-stakes patent...To view the full article, register now.
Already a subscriber? Click here to view full article